Several small- and mid-cap stocks posted notable gains in Wednesday's after-hours trading session, even though most companies did not release fresh news. The movement was largely driven by investor sentiment and sector momentum.Spyre Therapeutics, Inc. (SYRE) closed the after-hours session at $34.71, rising $1.65 or 4.99 percent as of 6:47 PM EST. Despite the absence of new company updates, the stock attracted strong interest from investors and led the list of gainers.The Oncology Institute, Inc. (TOI) end ...

U.S. President Donald Trump is expected to sign an executive order that would reclassify marijuana and ease federal restrictions on research that could lead to new medical marijuana products. Here is ... ...

U.S. President Donald Trump is expected to sign an executive order as soon as this week that would fast-track the reclassification of cannabis, NBC News reported on Tuesday, citing four people with di... ...

Top Canadian Cannabis Stocks to Watch This WeekCanadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships. Meanwhile, the U.S. cannabis industry continues expanding despite regulatory delays. Total U.S. cannabis sales now exceed $32 billion annually. Importantly, analysts project the market could surpass $50 billion by 2030. That growth outlook keeps Canadian operators ...

President Donald Trump on Monday reiterated that he is weighing whether to reclassify marijuana as a less dangerous drug, a statement that mirrors similar comments he made earlier this year and during his 2024 presidential campaign. Speaking to reporters in the Oval Office, the president said he was considering an executive order to reclassify marijuana as a Schedule III drug."We are considering that. A lot of people want to see it, the reclassification, because it leads to tremendous amounts of research th ...

President Donald Trump told reporters on Monday he is weighing an executive order to reclassify marijuana as a Schedule III substance. The potential action could transform the cannabis market, reduce legal punishments and allow for easier scientific research.TLRY stock is moving. See the chart and price action here. “We are looking at that very strongly,” Trump said in response to reports that he is looking at directing agencies to treat marijuana as a Schedule III drug.Read Next: Elon Musk Prepares SpaceX ...

Bill Schmitt Jr. (C) joins cannabis reform protesters outside the White House to call on U.S. President Joe Biden "to take action on cannabis clemency before the November general election” October 24, 2022 in Washington, DC.Pot stocks failed to light up for a second day on Monday even after President Donald Trump confirmed he's considering an executive order loosening regulations on marijuana.The Amplify Seymour Cannabis ETF (CNBS) took a leg up in afternoon trading after Trump said he was weighing reclassi ...

President Donald Trump said on Monday he is considering signing an executive order to reclassify marijuana as a less dangerous drug. ...

Aurora Cannabis Inc. (NASDAQ:ACB) ranks among the best sin stocks to buy in 2026. Aurora Cannabis Inc. (NASDAQ:ACB) has recently been making significant market growth in Europe and Australia, with the company stating on December 2 that its subsidiary, MedReleaf Australia, has signed a distribution agreement with Leafio, Montu Australia’s wholesale arm. The partnership intends to give medical professionals training materials while expanding patient access to medical cannabis products throughout Australia. ...

Within Canada’s tech sector, he said Celestica Inc. was impacted by some of the “AI skepticism.” Celestica shares finished 12.92% lower on the day, taking the most points off the index.Meanwhile, shares in Canada’s cannabis companies surged after reports that U.S. President Donald Trump is planning to ease federal restrictions on the drug.Shares of Tilray Brands Inc. gained 44.35%, while Canopy Growth Corp. shares were up 52.87%. Aurora Cannabis Inc. shares were up 19.04% and Organigram Global Inc. was up 1 ...